DFSVX
Price
$62.16
Change
-$0.03 (-0.05%)
Updated
Jul 31 closing price
Net Assets
19.45B
HTSCX
Price
$12.18
Change
-$0.01 (-0.08%)
Updated
Jul 31 closing price
Net Assets
305.4M
Interact to see
Advertisement

DFSVX vs HTSCX

DFSVX vs HTSCX Comparison Chart in %
View a ticker or compare two or three
VS
DFSVX vs. HTSCX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DFSVX is a StrongBuy and HTSCX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
DFSVX has more cash in the bank: 19.5B vs. HTSCX (305M). DFSVX pays higher dividends than HTSCX: DFSVX (1.50) vs HTSCX (0.13). DFSVX was incepted earlier than HTSCX: DFSVX (33 years) vs HTSCX (22 years). HTSCX (2.10) is less costly to investors than DFSVX (0.31). HTSCX is a more actively managed with annual turnover of: 60.00 vs. DFSVX (7.00). DFSVX has a lower initial minimum investment than HTSCX: DFSVX (0) vs HTSCX (2000). DFSVX annual gain was more profitable for investors over the last year : 34.39 vs. HTSCX (23.73). DFSVX return over 5 years is better than : 50.66 vs. HTSCX (8.22).
DFSVXHTSCXDFSVX / HTSCX
Total Expense Ratio0.312.0615%
Annual Report Gross Expense Ratio0.312.1015%
Fund Existence33 years22 years-
Gain YTD21.33622.16696%
Front LoadN/AN/A-
Min. Initial Investment02000-
Min. Initial Investment IRAN/AN/A-
Net Assets19.5B305M6,393%
Annual Yield % from dividends1.500.131,172%
Returns for 1 year34.3923.73145%
Returns for 3 years50.3729.23172%
Returns for 5 years50.668.22616%
Returns for 10 years107.7115.96675%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HSVRX54.680.40
+0.74%
Harbor Small Cap Value Admin
DESSX29.040.10
+0.35%
DWS Enhanced Core Equity S
AGIRX22.310.05
+0.22%
Alger Mid Cap Growth Institutional R
IAXSX9.86-0.03
-0.30%
VY® T. Rowe Price Divers Mid Cap Gr S
THISX89.95-1.09
-1.20%
T. Rowe Price Health Sciences I